Radiomics model based on multi-sequence MR images for predicting preoperative immunoscore in rectal cancer

K Xue, L Liu, Y Liu, Y Guo, Y Zhu, M Zhang - La radiologia medica, 2022 - Springer
Purpose To establish and validate a radiomics model based on multi-sequence magnetic
resonance (MR) images for preoperative prediction of immunoscore in rectal cancer …

[HTML][HTML] CX3CR1 acts as a protective biomarker in the tumor microenvironment of colorectal cancer

Y Yue, Q Zhang, Z Sun - Frontiers in immunology, 2022 - frontiersin.org
The tumor microenvironment (TME) plays an important role in the pathogenesis of many
cancers. We aimed to screen the TME-related hub genes of colorectal adenoma (CRAD) …

Current understanding of epigenetics role in melanoma treatment and resistance

M Karami Fath, A Azargoonjahromi, A Soofi… - Cancer cell …, 2022 - Springer
Melanoma is the most aggressive form of skin cancer resulting from genetic mutations in
melanocytes. Several factors have been considered to be involved in melanoma …

[HTML][HTML] A systematic review of phytochemicals from Chinese herbal medicines for non-coding RNAs-mediated cancer prevention and treatment: From molecular …

W Zhai, Y Hu, Y Zhang, G Zhang, H Chen, X Tan… - Medicine in Novel …, 2022 - Elsevier
Worldwide, cancer is a growing epidemic that results in large social and economic burdens.
Despite advances in current diagnosis and treatment, most of the prognosis in cancer …

Panax notoginseng saponins prevent colitis-associated colorectal cancer via inhibition IDO1 mediated immune regulation

LI Xue-Ming, Y Ding-Yi, LIU Ya-Hui, ZHU Lei… - Chinese Journal of …, 2022 - Elsevier
Colorectal cancer (CRC) is the third most lethal cancer and leading cause of cancer
mortality worldwide. A key driver of CRC development is colon inflammatory responses …

Immunotherapy in the Treatment of Advanced Colorectal Cancer

P Raman, G Botrus, T Bekaii-Saab - 2022 - Springer
Immunotherapy has rapidly evolved in the treatment of select malignancies. In colorectal
cancer, response to treatment has varied based on the presence of mismatch repair …

Identification and Characterization of p53 as a Regulator of CD80 in Colorectal Cancer

E Alibo - 2022 - search.proquest.com
Cancer is a disease characterized by a diverse amount of genetic mutations and epigenetic
alterations. Some of these changes confer a competitive advantage by allowing the tumor to …

Association of a 20-lncRNA signature with mutation load of colon adenocarcinoma and immune microenvironment

Y Lin, Q Li, Z Liu, R Liang, J Ye, Z He, X Gao, J Zhang… - 2022 - researchsquare.com
Purpose Tumor mutation burden (TMB) is an emerging biomarker for predicting immune
checkpoint inhibitors (ICI). However, the role of TMB associated with long non-coding RNAs …